ERBB3 and ovarian cancer: One of the studies from our collaborators using microfluidics-based isolation of tumor cells by targeting ERBB3 protein from blood samples of a parabiosis model of ovarian cancer was able to capture more than 90% of CTCs in the blood samples [7].